Searched for
CORBEVAX TRIAL
Biological E seeks nod for bivalent vax trialsBiological E has developed the protein subunit Covid vaccine Corbevax. The antigen used in the vaccine was developed by Texas Children’s Ho...- Vaccinated with Covaxin or Covishield? You may take Corbevax as precaution doseThe government has approved Biological E's Corbevax as a precaution dose for those above 18 years fully vaccinated with either Covishield o...
- NTAGI has found Corbevax efficient as a booster, govt may soon recommend it: Drug Controller General of IndiaThe National Technical Advisory Group on Immunisation (NTAGI) which reviewed the data of Corbevax earlier had found significant antibody re...
- 'Corbevax under WHO's detailed review for emergency use listing'The WHO website states that the rolling data submission has begun on June 10 and the decision date on EUL is yet to be confirmed. The compa...
- NTAGI to decide on including Corbevax as a booster dose in inoculation drive"We will review the data of Corbevax in our next meeting slated to happen this month and evaluate if mix and match of vaccines can be allow...
- Corbevax may soon get nod to be used as fresh boosterIndia's drug regulator on Saturday granted approval to Hyderabad-based Biological E's Covid-19 vaccine Corbevax to be allowed as a booster ...
- Corbevax gets DCGI nod as heterologous Covid booster dose for adultsThe vaccine can be administered after 6 months of administration of primary vaccination (two doses) of Covaxin or Covishield vaccines for r...
- Biological E. cuts price of its COVID-19 vaccine to Rs 250 per doseIt would result in end users paying a price of Rs 400 a dose, including taxes and administration charges, the company said in a statement. ...
- Biological E seeks EUA for Corbevax as booster in adults vaccinated with Covishield, CovaxinThe Drugs Controller General Of India (DCGI) had already approved Corbevax, India's first indigenously developed RBD protein subunit vaccin...
- Corbevax to cost Rs 800 in market & Rs 145 for the govt"Our price to the government programme is ₹145, the lowest in the country and possibly the world," Datla said. "It's something we take grea...
- Subject Expert Committee recommends EUA for BE's Covid jab Corbevax for 12-18 years age groupCorbevax, is a RBD protein sub-unit vaccine that has been developed with support from the Department of Biotechnology and the Biotechnology...
- Biological E seeks EUA for its Corbevax vaccine for 12-18 yrs age groupThe Drugs Controller General Of India (DCGI) has already approved Corbevax, which is India's first indigenously developed RBD protein sub-u...
- Centre places purchase order for 5 cr doses of Corbevax Covid vaccine each costing Rs 145 sans taxThe government is yet to decide on which segment of beneficiaries this new vaccine would be administered.
- Experts panel to review applications of Covovax & Corbevax jabs; Merck's Covid drug todayThe subject experts committee (SEC), a body under India's drug regulator, will meet on Monday to review the applications for granting appro...
- New Covid vaccine: Bio E may submit Corbevax trial data this monthThe government had estimated that Biological would account for 300 million jabs from August to December.
- BE hopes to roll out COVID-19 vaccine Corbevax by November-endSpeaking to reporters on the sidelines of signing a financing agreement with US International Development Finance Corporation (DFC), she sa...
- Biological E seeks DCGI's nod for phase-3 trial of Corbevax as booster dose in those vaccinated with Covishield or CovaxinCurrently, phase 2/3 clinical trials of the second indigenously developed Corbevax, an RBD protein sub-unit vaccine to be administered in a...
- Biological E gets nod for phase 2/3 clinical trial of its Covid vaccine on children above 5 years, adolescentsThe approval for conducting phase III comparator safety and immunogenicity trial in adults came after the SEC's review of Phase I and II cl...
- DCGI gives nod for phase 2/3 trials of Biological E's Covid vaccine on those aged between 5 & 18The phase 2 and 3 clinical trials have be conducted as per approved protocol titled 'A Prospective, Randomised, Double-blind, Placebo contr...
- Biological E's Corbevax could be the most affordable Covid vaccine in IndiaBiological E is working with Baylor College of Medicine (BCM) to make Corbevax. It is undergoing Phase 3 trials and has shown promising res...
Load More
